Centrum Broking
- All
- News
- Videos
-
Pay Hike To Lift Auto, Consumer Durable Stocks: Centrum Broking
Higher wages could also lead to a demand for real estate and this will also boost housing finance companies, he added.
-
Unified Payments System To Make Mobile Wallets Redundant: Report
Ongoing push by the Reserve Bank of India to revolutionize banking through the Unified Payments Interface (UPI) will leave mobile wallets redundant, as mobile banking has jumped over three-fold in February from the year-ago period, according to a report.
-
Pharma Sector May Post Good Growth in Q4: Centrum Broking
The pharma sector is expected to report good growth for the fourth quarter of 2015-16 despite regulatory concerns raised by US Food and Drug Administration (FDA) and the recent ban on 344 fixed dose combinations imposed by the government, a report by Centrum Broking said.
-
Sensex Not Overvalued, Banks to Outperform: Analysts
According to Centrum Broking's Abhishek Anand valuations continue to be comfortable. -On a one-year forward basis we are still marginally below the long-term average,- he said.
-
Revenue growth pressure may persist: Experts
Big companies like Oil & Natural Gas Corporation, State Bank of India and Tata Motors among others will determine how the earnings season will pan out, says an expert. In terms of revenue growth and EBITDA margin, the pressure on companies is going to continue in the fourth quarter as well as in the year ahead.
-
Pay Hike To Lift Auto, Consumer Durable Stocks: Centrum Broking
Higher wages could also lead to a demand for real estate and this will also boost housing finance companies, he added.
-
Unified Payments System To Make Mobile Wallets Redundant: Report
Ongoing push by the Reserve Bank of India to revolutionize banking through the Unified Payments Interface (UPI) will leave mobile wallets redundant, as mobile banking has jumped over three-fold in February from the year-ago period, according to a report.
-
Pharma Sector May Post Good Growth in Q4: Centrum Broking
The pharma sector is expected to report good growth for the fourth quarter of 2015-16 despite regulatory concerns raised by US Food and Drug Administration (FDA) and the recent ban on 344 fixed dose combinations imposed by the government, a report by Centrum Broking said.
-
Sensex Not Overvalued, Banks to Outperform: Analysts
According to Centrum Broking's Abhishek Anand valuations continue to be comfortable. -On a one-year forward basis we are still marginally below the long-term average,- he said.
-
Revenue growth pressure may persist: Experts
Big companies like Oil & Natural Gas Corporation, State Bank of India and Tata Motors among others will determine how the earnings season will pan out, says an expert. In terms of revenue growth and EBITDA margin, the pressure on companies is going to continue in the fourth quarter as well as in the year ahead.
